Cargando…
Identification of sentinel lymph nodes by contrast‐enhanced ultrasonography with Sonazoid in patients with breast cancer: a feasibility study in three hospitals
The aim of this prospective study was to evaluate the feasibility of periareolar injection of the contrast agent Sonazoid (SNZ) followed by ultrasonography (US) for the identification of sentinel lymph node (SLN) in breast cancer patients with clinically negative node. Patients (n = 100) with T1‐2N0...
Autores principales: | Shimazu, Kenzo, Ito, Toshikazu, Uji, Kumiko, Miyake, Tomohiro, Aono, Toyokazu, Motomura, Kazuyoshi, Naoi, Yasuto, Shimomura, Atsushi, Shimoda, Masafumi, Kagara, Naofumi, Kim, Seung Jin, Noguchi, Shinzaburo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5548878/ https://www.ncbi.nlm.nih.gov/pubmed/28766883 http://dx.doi.org/10.1002/cam4.1142 |
Ejemplares similares
-
Highly sensitive detection of sentinel lymph node metastasis of breast cancer by digital PCR for RASSF1A methylation
por: Abe, Mizuho, et al.
Publicado: (2019) -
BRCA1 promoter methylation of normal breast epithelial cells as a possible precursor for BRCA1-methylated breast cancer
por: Otani, Yoko, et al.
Publicado: (2014) -
Vasculogenic mimicry is associated with trastuzumab resistance of HER2-positive breast cancer
por: Hori, Ami, et al.
Publicado: (2019) -
Promoter methylation of TRIM9 as a marker for detection of circulating tumor DNA in breast cancer patients
por: Mishima, Chieko, et al.
Publicado: (2015) -
Enhanced humoral immunity in breast cancer patients with high serum concentration of anti‐HER2 autoantibody
por: Sato, Yasufumi, et al.
Publicado: (2021)